PDL BioPharma, Inc. (PDLI) Tops Q3 EPS by 1c, Sales Beat Expectations
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
Net income per basic share (in dollars per share): 0.08
Today's EPS Names:
MAXN, CSTR, ACU, More
Financial Fact:
Net income per basic share (in dollars per share): 0.08
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
PDL BioPharma, Inc. (NASDAQ: PDLI) reported Q3 EPS of $0.28, $0.01 better than the analyst estimate of $0.27. Revenue for the quarter came in at $83.8 million versus the consensus estimate of $82.85 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BiomX Inc. (PHGE) Appoints Susan Blum to its Board
- Marten Transport (MRTN) Misses Q1 EPS by 2c
- Genuine Parts (GPC) Tops Q1 EPS by 5c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
